新型氨酸衍生物SKA-346作为KCa3.1通道选择性激活剂
Brandon Han Siang Wong1,2, Heesung Shim3, Stephanie Shee Min Goay1,4
1Lee Kong Chian School of Medicine, Nanyang Technological University Singapore Singapore nkverma@ntu.edu.sg.
一种新类衍生物SKA-346选择性地激活KCa3.1通道,这是T细胞免疫反应的关键参与者. 这一发现为提升T细胞癌症治疗提供了有前途的途径.
科学领域:
- 离子通道药理学 离子通道药理学
- 免疫学 免疫学 免疫学
- 药品化学 药品化学 是一个
背景情况:
- 激活通道亚型3.1 (KCa3.1) 对T细胞功能和免疫反应至关重要.
- 通过K+通道调节增强T细胞细胞毒性是癌症免疫疗法的潜在策略.
研究的目的:
- 为了识别和描述KCa3.1通道的选择性激活器.
- 探索KCa3.1激活剂在促进T细胞介导癌症细胞毒性的潜力.
主要方法:
- 合成五种氨酸衍生物.
- 对KCa3.1和14种其他离子通道的衍生品进行电生理学选.
- 在使用RosettaLigand和GLIDE的基分子对接.
- 在腹腔内给药后对小鼠进行的药理动力学研究.
主要成果:
- SKA-346选择性激活了KCa3.1,EC50为1.9微米.
- 在分析中发现,SKA-346在KCa3.1通道内具有特定的结合姿势.
- 在小鼠中,SKA-346表现出有利的药理动力学特性,包括良好的耐受性和2.8小时的半衰期.
结论:
- SKA-346是一种强效和选择性的KCa3.1通道激活器.
- 这些发现支持SKA-346的发展,作为针对T细胞细胞毒性的新型癌症免疫疗法的主要化合物.
更多相关视频
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
